Skip to content

Penyagolosa Trail Saludable Women

Penyagolosa Trail Saludable Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03990259
Acronym
PTSW
Enrollment
50
Registered
2019-06-18
Start date
2019-02-25
Completion date
2019-04-16
Last updated
2019-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Exertion

Keywords

Ultraendurance, Sex differences, Performance, Genetics, Physiological damage

Brief summary

This study has as main objective to asses different genetic, biochemical and physiological biomarkers affecting performance and health status in ultraendurance runners according to individual's sex.

Detailed description

Ultraendurance races has been shown to impact on several health-related biomarkers, and therefore they may have detrimental effects on runners' health. In this study, we aim to analyze the impact of running a 107,6 km mountain race in ultraendurance runners splitting our sample by individual's sex. To do this, baseline measurements of the runners have been collected through stress tests and biochemical analyses of blood and urine samples. Indeed, a saliva sample was collected to isolated a genomic DNA sample of each runner. During the race anthropometrical, ventilatory and strength data was collected in three different moments and after crossing the finish line. Indeed, after completed the ultraendurance mountain race, blood and urine samples were taken at the finish line, as well as 24h and 48h post-race.

Interventions

OTHERRunning the CSP Mountain Race

The runners completed a 107,6 km mountain race

Sponsors

Club Deportivo Marató i Mitja Castelló-Penyagolosa
CollaboratorUNKNOWN
Fundación Vithas-Nisa
CollaboratorUNKNOWN
Hospital Vithas-Nisa 9 de Octubre
CollaboratorUNKNOWN
Universitat Jaume I
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults (\>18 years old) * Volunteers should be finish at least one ultraendurance mountain race (\>60km).

Exclusion criteria

* Having heart disease * Having kidney disease * Taking a medication on an ongoing basis

Design outcomes

Primary

MeasureTime frameDescription
Telomere length, genetic marker related to biological aging12 hours before the raceAnalysis of the telomere length in genomic DNA samples, which were isolated from saliva samples of each participant
Change in the biochemical parameters related to immunological response12 hours before the race, 15 minutes after the race, 24 hours after the race and 48 hours after the raceBlood concentration of erythrocytes, hematocrit, leukocytes, neutrophils, lymphocytes, monocytes, eosinophils, basophils, and platelet volume. The concentration of each cell type is expressed in number of cells per volume (cells per liter)
Change in the power level12 hours before the race, 15 minutes after the raceSquat Jump (high of the jump measured in centimeters)
Change in the lung function12 hours before the race, and 15 minutes after the racePulmonary function test by spirometry. The parameters measured are vital capacity (VC), forced vital capacity (FVC), maximal mid-expiratory flow (MEF) and total lung capacity. Outcome data of all these parameters are expressed in liters.
Change in the lung function related to time12 hours before the race, and 15 minutes after the racePulmonary function test by spirometry. The parameters measured are forced expiratory volume in 1 second (FEV1) and in 6 seconds (FEV6) and peak expiratory flow (PEF). Outcome data of all these parameters are expressed in liters per second.
Change in the Strength level12 hours before the race, in three moments during the race (after running 33km, 65km and 94 km), and 15 minutes after the raceHand grip (pressure in kilograms)
Change in the Ventilatory Flow60 minutes before the race, in three moments during the race (after running 33km, 65km and 94 km), and 15 minutes after the raceVentilatory Flow measurement (liters per minute)
Change in the biochemical parameters related to dehydration and kidney injury60 minutes before the race and 15 minutes after the raceUrine test to measure the concentration of sodium and creatinine, as well as urine density
Analysis of tne changes in the Physical activity dataFrom 9 hours before starting the race to 48 hours after crossing the finish line.Physical activity measured by wearing accelerometer devices. Physical activity defined as sedentary, light, moderate, vigorous, very vigorous and extremely vigorous. The aim to wear accelerometers devices is to monitor individuals.
Analysis of the presence or absence of genetic markers related to endurance performance and ability to muscle damage recovery12 hours before the raceAnalysis of different polymorphisms in genomic DNA samples, which were isolated from the saliva sample of each participant.
Change in the biochemical parameters related to kidney injury, dehydration, inflammation, and cardiac damage12 hours before the race, 15 minutes after the race, 24 hours after the race and 48 hours after the raceBlood concentration of estradiol, testosterone, progesterone, creatinine, troponin, C-reactive protein, hemoglobin, sodium, potassium, chlorine, iron, and ferritin. Concentration of all these parameters is expressed in mass per volume (i.e. nanograms per milliliter)
Change in the biochemical parameters related to muscle damage12 hours before the race, 15 minutes after the race, 24 hours after the race and 48 hours after the raceBlood concentration of lactate dehydrogenase and creatine kinase. The enzyme concentration is expressed in units per volume (enzyme units per milliliter)

Secondary

MeasureTime frameDescription
Self-reported questionnaire about training habitsOne month before the race dayPersonal questionnaire asking for training habits. Multiple-choice questions. Participants choose one of the different possible answers. Data is encoded as a factor variable with different levels.
Self-reported questionnaire about menstrual cycle (only for females)One month before the race dayPersonal questionnaire asking for training habits. Open-ended questions. Females answer questions regarding menstrual cycle (duration, dates, regularity, quantity of bleeding, pregnancy history, dysmenorrhea).
Assesment of physical condition by cardiopulmonary testOne month before the race dayMaximal oxygen consumption (milliliters of oxygen used in one minute per kilogram of body weight)
Analysis of body composition (proportion of body fat, fat-free mass and water) per body areas (trunk, arms and legs)12 hours before the race, and 15 minutes after the race,Bioimpedance analysis (percentage of body fat, fat-free mass and water)
Heart rateThrough race completion (the time that a runner is performing the 107 kilometers of the race, an average of 25 hours)Recording the number of contractions of the heart per minute (bpm) by using a heart rate monitor during the race
Evaluation of effort subjective perception60 minutes before the race, in three moments during the race (after running 33km, 65km and 94 km), and 15 minutes after the raceBorg ratings of perceived exertion (CR10). Scale with ten levels (0-Nothing at all, and 10-Extremely)
Evaluation of muscle damage subjective perception per body areas12 hours before the race, 15 minutes after the race, and 48 hours after the raceEvaluation of perceived muscle damage in a 10-level scale. Scale with ten levels (0-Nothing at all, and 10-Extremely)
Change in the body mass60 minutes before the race, in three moments during the race (after running 33km, 65km and 94 km), and 15 minutes after the race,Body mass measurement (weight in kilograms)
Self-reported questionnaire about social and health statusOne month before the race dayPersonal questionnaire asking for social status. Multiple-choice questions. Participants choose one of the different possible answers. Data is encoded as a factor variable with different levels.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026